INS and cancer: IR-A is expressed predominantly in embryonic and fetal tissues, in the central nervous system (CNS) and hematopoietic cells and is frequently upregulated in cancer cells, whereas IR-B is expressed mainly in the liver, fat and muscle where it binds insulin with high affinity and mediates its metabolic functions.